The Shanghai and Shenzhen stock exchnages are drafting regulatory changes to allow US-listed Chinese tech firms to list in the domestic market, thus enabling domestic investors to buy shares in firms like Alibaba, Tencent, and Baidu. WeChat has more than 1 billion monthly active users, over 400 million people use Alibaba monthly, and the company's shares have rocketed 170% since listing... but domestic investors havn't been able to get on board and invest in the securities.
Last year, the Hong Kong Exchnage announced plans to help Chinese tech behemoths list in Hong Kong. These plans were introduced to attract new tech IPOs, and secondary IPOs from the likes of Baidu, Alibaba, and JD.com who have traditionally chosen to list in the US.
Now China is also bidding against Hong Kong to bring its local champions back home. On March 30, China’s securities regulator, the CSRC, announced a pilot scheme to encourage the same group of companies to list in Shanghai and Shenzhen.
The CSRC is looking to implement China Deposit Receipts to allow trading on domestic exchanges. A pilot of Chinese depositary receipts would apply to companies that went public overseas and have a market value of more than 200 billion yuan ($32 billion). Alibaba, Baidu, JD.com, Weibo and NetEase, are said to be the first group of US-listed Chinese tech giants to float on local exchanges through CDRs, as reported by local media Caixin.
The migration to China could bring a valuation boost to US-listed Chinese tech stocks. In the past, Chinese stocks that have come back to the mainland and relisted have commanded higher valuations. An example is Internet security company Qihoo 360, which delisted from the US in 2016 and now has almost quadrupled its market capitalisation after an A-share refloat.
Gaming company Giant Interactive Group delisted in 2014 and its value leapt fourfold upon re-float. Iflytek , a Chinese Artificial Intelligence firm, is listed on the Shenzhen exchange and is valued at 174 times reported earnings.
The drive to relist will most likely expand P/E multiples as local Chinese investors gain access to their homegrown technology companies for the first time.
CQQQ: This Chinese Technology ETF tracks the performance of the AlphaShares China Technology Index and contains 80 Hong Kong- and US-listed Chinese tech stocks.
The percentage appreciation since May 2017 has outperformed the CSI300, Nasdaq, and H-shares indices. It is not, however, a true measure of US-listed Chinese tech stocks' performance as CQQQ includes HK-listed securities.
US-listed Chinese tech stocks outperform
Below you can see a custom index of all the 27 US listed Chinese tech stocks in the CQQQ ETF charted,normalised by percentage appreciation against the CQQQ ETF, Nasdaq, H-shares, and CSI300. The US listed component of CQQQ appears to outperform (45.08% appreciation) the Chinese technology ETF (26.86% appreciation).
Beijing is also targeting the likes of Baidu, Alibaba Group, and JD.com by allowing them to list at home via secondary listings –business that has also been high on Hong Kong’s agenda.
Our custom index of 27 US-listed Chinese tech firms:
| JD.com Autohome Inc. Alibaba Group Holding Ltd. Baidu Inc. Bitauto Holdings Ltd. Baozun Inc. Cheetah Mobile Inc. Changyou.com Ltd. Daqo new Energy Corp. | Phoenix New Media Ltd. GDS Holdings Ltd. JA Solar Holdings Co. Ltd. Jinkosolar Holding Co. Ltd. Link Motion Inc. Momo Inc. Netease Inc. Renren Inc. Fang Holdings Ltd. | Sina Corp./China SOHU.com Inc. Tencent Holdings Ltd. 21Vianet Group Inc. Weibo Corp. 58.com Inc. Xunlei Ltd. Yirendai Ltd. YY Inc. |
2024: The wasted year
Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.
As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.
Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.
With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.
Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.
Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.
As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.
Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.
With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.
Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)
